-
公开(公告)号：US08080646B2
公开(公告)日：2011-12-20
申请号：US12402854
申请日：2009-03-12
申请人： Michael Aidan North , Karin Kristina Amundson , Vahe Bedian , Shelly Sims Belouski , Dana Dan Hu-Lowe , Xin Jiang , Shannon Marie Karlicek , Sirid Aimee Kellerman , James Arthur Thomson , Jianying Wang , Grant Raymond Wickman , Jingchuan Zhang
发明人： Michael Aidan North , Karin Kristina Amundson , Vahe Bedian , Shelly Sims Belouski , Dana Dan Hu-Lowe , Xin Jiang , Shannon Marie Karlicek , Sirid Aimee Kellerman , James Arthur Thomson , Jianying Wang , Grant Raymond Wickman , Jingchuan Zhang
CPC分类号： C07K16/40 , A61K2039/505 , C07K16/2863 , C07K2317/21 , C07K2317/33 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/77 , C07K2317/92
摘要： The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to the extracellular domain (ECD) of activin receptor-like kinase-1 (ALK-1) and that function to abrogate the ALK-1/TGF-beta-1/Smad1 signaling pathway. The invention also relates to heavy and light chain immunoglobulins derived from human anti-ALK-1 antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-ALK-1 antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention.
摘要翻译： 本发明涉及包含结合活化素受体样激酶-1（ALK-1）的细胞外结构域（ECD）的人抗体及其抗原结合部分的抗体，其功能是消除ALK-1 / TGF-β -1 / Smad1信号通路。 本发明还涉及源自人抗ALK-1抗体的重链和轻链免疫球蛋白和编码这种免疫球蛋白的核酸分子。 本发明还涉及制备人抗ALK-1抗体的方法，包含这些抗体的组合物和使用抗体和组合物的方法。 本发明还涉及包含本发明的核酸分子的转基因动物或植物。
-
公开(公告)号：US07537762B2
公开(公告)日：2009-05-26
申请号：US11517530
申请日：2006-09-06
申请人： Michael Aidan North , Karin Kristina Amundson , Vahe Bedian , Shelley Sims Belouski , Dana Dan Hu-Lowe , Xin Jiang , Shannon Marie Karlicek , Sirid Aimee Kellerman , James Arthur Thomson , Jianying Wang , Grant Raymond Wickman , Jingchuan Zhang
发明人： Michael Aidan North , Karin Kristina Amundson , Vahe Bedian , Shelley Sims Belouski , Dana Dan Hu-Lowe , Xin Jiang , Shannon Marie Karlicek , Sirid Aimee Kellerman , James Arthur Thomson , Jianying Wang , Grant Raymond Wickman , Jingchuan Zhang
IPC分类号： A61K39/395 , C07K16/40
CPC分类号： C07K16/40 , A61K2039/505 , C07K16/2863 , C07K2317/21 , C07K2317/33 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/77 , C07K2317/92
摘要： The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to the extracellular domain (ECD) of activin receptor-like kinase-1 (ALK-1) and that function to abrogate the ALK-1/TGF-beta-1/Smad1 signaling pathway. The invention also relates to heavy and light chain immunoglobulins derived from human anti-ALK-1 antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-ALK-1 antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention.
摘要翻译： 本发明涉及包含结合活化素受体样激酶-1（ALK-1）的细胞外结构域（ECD）的人抗体及其抗原结合部分的抗体，其功能是消除ALK-1 / TGF-β -1 / Smad1信号通路。 本发明还涉及源自人抗ALK-1抗体的重链和轻链免疫球蛋白和编码这种免疫球蛋白的核酸分子。 本发明还涉及制备人抗ALK-1抗体的方法，包含这些抗体的组合物和使用抗体和组合物的方法。 本发明还涉及包含本发明的核酸分子的转基因动物或植物。
-
公开(公告)号：US20100197005A1
公开(公告)日：2010-08-05
申请号：US12402854
申请日：2009-03-12
申请人： Shelley Sims Belouski , Sirid-Aimee Kellermann , Michael Aidan North , Karin Kristina Amundson , Vahe Bedian , Dana Dan Hu-Lowe , Xin Jiang , Shannon Marie Karlicek , James Arthur Thomson , Jianying Wang , Grant Raymond Wickman , Jingchuan Zhang
发明人： Shelley Sims Belouski , Sirid-Aimee Kellermann , Michael Aidan North , Karin Kristina Amundson , Vahe Bedian , Dana Dan Hu-Lowe , Xin Jiang , Shannon Marie Karlicek , James Arthur Thomson , Jianying Wang , Grant Raymond Wickman , Jingchuan Zhang
CPC分类号： C07K16/40 , A61K2039/505 , C07K16/2863 , C07K2317/21 , C07K2317/33 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/77 , C07K2317/92
摘要： The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to the extracellular domain (ECD) of activin receptor-like kinase-1 (ALK-1) and that function to abrogate the ALK-1/TGF-beta-1/Smad1 signaling pathway. The invention also relates to heavy and light chain immunoglobulins derived from human anti-ALK-1 antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-ALK-1 antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention.
摘要翻译： 本发明涉及包含结合活化素受体样激酶-1（ALK-1）的细胞外结构域（ECD）的人抗体及其抗原结合部分的抗体，其功能是消除ALK-1 / TGF-β -1 / Smad1信号通路。 本发明还涉及源自人抗ALK-1抗体的重链和轻链免疫球蛋白和编码这种免疫球蛋白的核酸分子。 本发明还涉及制备人抗ALK-1抗体的方法，包含这些抗体的组合物和使用抗体和组合物的方法。 本发明还涉及包含本发明的核酸分子的转基因动物或植物。
-
公开(公告)号：US09221915B2
公开(公告)日：2015-12-29
申请号：US13282065
申请日：2011-10-26
申请人： Shelley Sims Belouski , Sirid-Aimée Kellerman , Michael Aidan North , Karin Kristina Amundson , Vahe Bedian , Dana Dan Hu-Lowe , Xin Jiang , Shannon Marie Karlicek , James Arthur Thomson , Jianying Wang , Grant Raymond Wickman , Jingchuan Zhang
发明人： Shelley Sims Belouski , Sirid-Aimée Kellerman , Michael Aidan North , Karin Kristina Amundson , Vahe Bedian , Dana Dan Hu-Lowe , Xin Jiang , Shannon Marie Karlicek , James Arthur Thomson , Jianying Wang , Grant Raymond Wickman , Jingchuan Zhang
CPC分类号： C07K16/40 , A61K2039/505 , C07K16/2863 , C07K2317/21 , C07K2317/33 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/77 , C07K2317/92
摘要： The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to the extracellular domain (ECD) of activin receptor-like, kinase-1 (ALK-1) and that function to abrogate the ALK-1/TGF-beta-1/Smad1 signaling pathway. The invention also relates to heavy and light chain immunoglobulins derived from human anti-ALK-1 antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-ALK-1 antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention.
摘要翻译： 本发明涉及抗体，其包括结合激活素受体样激酶-1（ALK-1）的细胞外结构域（ECD）的人抗体及其抗原结合部分，其功能是消除ALK-1 / TGF- β-1 / Smad1信号通路。 本发明还涉及源自人抗ALK-1抗体的重链和轻链免疫球蛋白和编码这种免疫球蛋白的核酸分子。 本发明还涉及制备人抗ALK-1抗体的方法，包含这些抗体的组合物和使用抗体和组合物的方法。 本发明还涉及包含本发明的核酸分子的转基因动物或植物。
-
公开(公告)号：US20120052074A1
公开(公告)日：2012-03-01
申请号：US13282065
申请日：2011-10-26
申请人： Shelley Sims Belouski , Sirid-Aimée Kellerman , Michael Aidan North , Karin Kristina Amundson , Vahe Bedian , Dana Dan Hu-Lowe , Xin Jiang , Shannon Marie Karlicek , James Arthur Thomson , Jianying Wang , Grant Raymond Wickman , Jingchuan Zhang
发明人： Shelley Sims Belouski , Sirid-Aimée Kellerman , Michael Aidan North , Karin Kristina Amundson , Vahe Bedian , Dana Dan Hu-Lowe , Xin Jiang , Shannon Marie Karlicek , James Arthur Thomson , Jianying Wang , Grant Raymond Wickman , Jingchuan Zhang
IPC分类号： A61K39/395 , A61P27/02 , A61P17/06 , A61P31/04 , A61P27/06 , A61P29/00 , A61P31/12 , A61P35/00 , A61P19/02
CPC分类号： C07K16/40 , A61K2039/505 , C07K16/2863 , C07K2317/21 , C07K2317/33 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/77 , C07K2317/92
摘要： The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to the extracellular domain (ECD) of activin receptor-like, kinase-1 (ALK-1) and that function to abrogate the ALK-1/TGF-beta-1/Smad1 signaling pathway. The invention also relates to heavy and light chain immunoglobulins derived from human anti-ALK-1 antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-ALK-1 antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention.
摘要翻译： 本发明涉及抗体，其包括结合激活素受体样激酶-1（ALK-1）的细胞外结构域（ECD）的人抗体及其抗原结合部分，其功能是消除ALK-1 / TGF- β-1 / Smad1信号通路。 本发明还涉及源自人抗ALK-1抗体的重链和轻链免疫球蛋白和编码这种免疫球蛋白的核酸分子。 本发明还涉及制备人抗ALK-1抗体的方法，包含这些抗体的组合物和使用抗体和组合物的方法。 本发明还涉及包含本发明的核酸分子的转基因动物或植物。
-
公开(公告)号：US20070065444A1
公开(公告)日：2007-03-22
申请号：US11517530
申请日：2006-09-06
申请人： Michael North , Karin Amundson , Vahe Bedian , Shelley Belouski , Dana Hu-Lowe , Xin Jiang , Shannon Karlicek , Sirid Kellermann , James Thomson , Jianying Wang , Grant Wickman , Jingchuan Zhang
发明人： Michael North , Karin Amundson , Vahe Bedian , Shelley Belouski , Dana Hu-Lowe , Xin Jiang , Shannon Karlicek , Sirid Kellermann , James Thomson , Jianying Wang , Grant Wickman , Jingchuan Zhang
IPC分类号： A61K39/395 , C07K16/40
CPC分类号： C07K16/40 , A61K2039/505 , C07K16/2863 , C07K2317/21 , C07K2317/33 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/77 , C07K2317/92
摘要： The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to the extracellular domain (ECD) of activin receptor-like kinase-1 (ALK-1) and that function to abrogate the ALK-1/TGF-beta-1/Smad1 signaling pathway. The invention also relates to heavy and light chain immunoglobulins derived from human anti-ALK-1 antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-ALK-1 antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention.
摘要翻译： 本发明涉及包含结合活化素受体样激酶-1（ALK-1）的细胞外结构域（ECD）的人抗体及其抗原结合部分的抗体，其功能是消除ALK-1 / TGF-β -1 / Smad1信号通路。 本发明还涉及源自人抗ALK-1抗体的重链和轻链免疫球蛋白和编码这种免疫球蛋白的核酸分子。 本发明还涉及制备人抗ALK-1抗体的方法，包含这些抗体的组合物和使用抗体和组合物的方法。 本发明还涉及包含本发明的核酸分子的转基因动物或植物。
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.056 秒)
